Search
Regulatory Story
Company UDG Healthcare Public Limited Co.
TIDM UDG
Headline Directorate Changes
Released 16:00 26-Mar-2019
Number 0769U16

RNS Number : 0769U
UDG Healthcare Public Limited Co.
26 March 2019
 

UDG Healthcare plc

("UDG" or "the Company")

26 March 2019

Directorate Changes

UDG is pleased to announce the following directorate changes:

Appointment of a new Senior Independent Director

Chris Brinsmead, who will in April have served more than nine years on the Board, is stepping down from the role of Senior Independent Director, effective 1 May 2019. Myles Lee, who joined the Board in April 2017, will assume the role of Senior Independent Director from this date.

Peter Gray, Chairman of UDG commented "I would like to thank Chris for his support and service as Senior Independent Director and would like to welcome Myles to the role of Senior Independent Director".

Committee Appointments

Following their recent appointment to the Board, Shane Cooke will become a member of the Risk, Investment and Financing Committee while Peter Chambre will be appointed to the Remuneration Committee. Both appointments are effective from 1 May 2019.

This announcement is made in accordance with Listing Rule 9.6.11(3).

 

 

 

For further information, please contact:

 

 

UDG Healthcare plc

Damien Moynagh

General Counsel & Company Secretary

+353 (1) 468 9000

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAKMGZFKVNGLZM
London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.